Anti-Mullerian hormone and antral follicle count as predictors of ovarian reserve and successful IVF

William, 2009, Anti-Mullerian Hormone and the Embryologist 2009, J Clin Embryol, 12, 15 Freour, 2006, Anti-mullerian hormone: clinical relevance in assisted reproductive therapy, Ann Endocrinol (Paris), 67, 567, 10.1016/S0003-4266(06)73008-6 Maseelall, 2009, Antral follicle count is a significant predictor of live birth in vitro fertilization cycles, Fertil Steril, 91, 1595, 10.1016/j.fertnstert.2008.11.001 Kwee, 2007, Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization, Reprod Biol Endocrinol, 5, 9, 10.1186/1477-7827-5-9 La Marca, 2006, Serum anti-Mullerian hormone throughout the human menstrual cycle, Hum Reprod, 21, 3103, 10.1093/humrep/del291 Visser, 2006, Role of anti-Mullerian hormone in follicle recruitment and maturation, J Gynecol Obstet Biol Reprod (Paris), 35, 2S30 Smeenk, 2007, Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection, Fertil Steril, 87, 223, 10.1016/j.fertnstert.2006.06.019 Talebian, 2008, Assessing antimullerian hormone (AMH) as a marker of ovarian response in anonymous oocyte donors: quantity or quality?, Fert Steril, 90, S267, 10.1016/j.fertnstert.2008.07.1249 Feyereisen, 2006, Anti-Mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status, Reprod Biomed Online, 12, 695, 10.1016/S1472-6483(10)61081-4 Hehenkamp, 2006, Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation, J Clin Endocrinol Metab, 91, 4057, 10.1210/jc.2006-0331 La Marca, 2007, Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology, Hum Reprod, 22, 766, 10.1093/humrep/del421 Yin, 2008, AMH level in follicular fluid and serum may predict outcome of IVF-ET in PCOS patients, Fert Steril, 90, S377, 10.1016/j.fertnstert.2008.07.1565 Ebner, 2006, Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles, Hum Reprod, 21, 2022, 10.1093/humrep/del127 Razieh, 2008, Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles, Arch Iranian Med, 11, 371 Ferraretti, 2011, ESHRE working group on poor ovarian response definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization, Hum Reprod, 26, 1616, 10.1093/humrep/der092 Nelson, 2007, Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy, Hum Reprod, 22, 2414, 10.1093/humrep/dem204 Ficicioglu, 2006, Early follicular anti-Mullerian hormone as an indicator of ovarian reserve, Fertil Steril, 85, 592, 10.1016/j.fertnstert.2005.09.019 Seifer, 2002, Early follicular serum Mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles, Fertil Steril, 77, 468, 10.1016/S0015-0282(01)03201-0 Broer, 2010, The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome, Curr Opin Obstet Gynecol, 22, 193, 10.1097/GCO.0b013e3283384911